Dana Farber Cancer Institute

Dana Farber Cancer Institute was paid $1.81M by Medicaid between Nov 2019 and May 2020, across 50 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 16% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	1,840	$301K
2020	8,524	$1.50M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	16%	658	313	$291K
80053	Comprehensive metabolic panel	14%	871	527	$252K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	8.4%	485	383	$152K
96375	Therapeutic injection; each additional sequential IV push	8.3%	441	234	$149K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	8.1%	719	460	$147K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.5%	362	272	$100K
96415		3.5%	69	40	$64K
96409		3.4%	244	147	$61K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.3%	971	612	$60K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	3.2%	148	131	$58K
96411		3.2%	188	137	$57K
74177	Computed tomography, abdomen and pelvis; with contrast material	2.9%	32	32	$53K

38 more codes

71260	Computed tomography, thorax, diagnostic; with contrast material	2.1%	46	$38K
96417		1.7%	97	$30K
80050	General health panel	1.4%	56	$25K
J0185	Injection, aprepitant, 1 mg	1.4%	46	$25K
83735		1.2%	599	$22K
86850		1.1%	316	$20K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.0%	89	$19K
99443		<1%	63	$17K
36430		<1%	20	$16K
99205	Prolong outpt/office vis	<1%	32	$15K
86901		<1%	316	$14K
86900		<1%	317	$14K
85027		<1%	335	$13K
82378		<1%	122	$13K
84100		<1%	462	$12K
82248		<1%	423	$9K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	17	$9K
83615		<1%	204	$7K
85007		<1%	327	$7K
80076		<1%	43	$5K
96367		<1%	38	$5K
99442		<1%	19	$4K
J9370	Vincristine sulfate, 1 mg	<1%	181	$4K
82247		<1%	169	$3K
84439		<1%	49	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	15	$2K
82784		<1%	20	$2K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	50	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	219	$2K
82565		<1%	53	$1K
84450		<1%	61	$1K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	17	$917.66
J8540	Dexamethasone, oral, 0.25 mg	<1%	159	$830.76
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	126	$773.48
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	17	$519.85
84520		<1%	16	$333.28
J2704	Injection, propofol, 10 mg	<1%	15	$139.55
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	22	$27.72

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWERGER, ANNETTE (PNP)